BioSpace News Archive

National network commits $550,000 during National Poverty Awareness Month investment series

32 Leading Experts to Provide Answers For Millions of People Living with Migraine

Alnylam Pharmaceuticals, Inc. announced today that it will report financial results for the fourth quarter and year ending December 31, 2018 on Thursday, February 7, 2019, after the U.S. financial markets close.

HCP, Inc. announced today that its Board of Directors declared a quarterly common stock cash dividend of $0.37 per share.

Revenues of $56.2 billion for the third quarter, up 5% year over year.

A groundbreaking study has launched in Leeds to better understand how proteins in people’s blood can help identify the risk of disease and enable health professionals to decide on the right care to prevent it.

Direct Relief today announced it received a $5.1 million donation from Virgil Elings to complete funding for its new headquarters facility. The $40 million facility, which was dedicated today, includes both Direct Relief’s headquarters offices and the largest distribution hub for humanitarian medical aid in the United States.

Expanding at a rather modest annual growth rate of 4.6 percent, the global market for oxycodone is projected to reach a revenue of US$ 4 Billion in 2028—showcasing an absolute dollar opportunity of US$ 181.3 Mn, through 2018-2019.

According to a recent research analysis compiled by Future Market Insights (FMI), a CAGR of over 20% has been projected for the global market for medication management system during the assessment period (2017-2026).

The brain monitoring systems market is projected to expand at a healthy pace with global sales exceeding US$ 3.5 Bn by end of 2019, as per the latest research study by FMI.